Expression and clinical significance of thrombospondin-1 and plasminogen activator inhibitor-1 in patients with mesangial proliferative glomerulonephritis.
Sign Up to like & getrecommendations! Published in 2020 at "Annals of palliative medicine"
DOI: 10.21037/apm-20-1291
Abstract: BACKGROUND As a common pathological type of glomerular disease in China, mesangial proliferative glomerulonephritis is related to plasminogen activator inhibitor-1 (PAI-1) and thrombospondin-1 (TSP-1). Here, this study aims to investigate the expression and clinical significance… read more here.
Keywords: pai; proliferative glomerulonephritis; mesangial hyperplasia; mesangial proliferative ... See more keywords
Overlap of Thrombotic Microangiopathy and Mesangial Proliferative Glomerulonephritis Caused by Combination Therapy with Atezolizumab and Bevacizumab
Sign Up to like & getrecommendations! Published in 2022 at "Internal Medicine"
DOI: 10.2169/internalmedicine.9425-22
Abstract: Vascular endothelial growth factor inhibitors and checkpoint inhibitors are effective treatments for solid tumors. These new classes of anti-cancer agents frequently cause kidney-related side effects. Although their anti-cancer effects may be enhanced when used in… read more here.
Keywords: thrombotic microangiopathy; mesangial proliferative; combination; glomerulonephritis caused ... See more keywords